NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase
RxNorm 391521
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 391521 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Glyceraldehyde-3-phosphate dehydrogenase (NAD(P)) (phosphorylating)
(Atom ID: 1632097)
SY
Synonym (SY):
Glyceraldehyde-3-phosphate dehydrogenase (nicotinamide adenine dinucleotide phosphate) (phosphorylating)
(Atom ID: 5939625)
FN
Full form of descriptor (FN):
Glyceraldehyde-3-phosphate dehydrogenase (nicotinamide adenine dinucleotide phosphate) (phosphorylating) (substance)
(Atom ID: 5939626)
SY
Synonym (SY):
NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase
(Atom ID: 1632098)
SY